BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30041940)

  • 1. Narrow Band Imaging reduces persistence of cancer in patients with pT1 high grade bladder cancer.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Mavilla L; Tariciotti P; Rizzo G; Fabi F; Falavolti C; Aloisi P; Vincenti G; Tema G; Lombardo R
    Eur J Surg Oncol; 2019 Mar; 45(3):466-470. PubMed ID: 30041940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer.
    Montanari E; de la Rosette J; Longo F; Del Nero A; Laguna P
    Arch Ital Urol Androl; 2012 Dec; 84(4):179-83. PubMed ID: 23427740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection.
    Schraml J; Silva JDC; Babjuk M
    Curr Opin Urol; 2018 Nov; 28(6):591-597. PubMed ID: 30102624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?
    Soria F; D'Andrea D; Moschini M; Giordano A; Mazzoli S; Pizzuto G; Hurle R; Colombo R; Briganti A; Altieri V; Shariat SF; Gontero P
    Urol Oncol; 2020 Mar; 38(3):77.e1-77.e7. PubMed ID: 31526650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
    Herr HW
    Eur Urol; 2015 Apr; 67(4):605-8. PubMed ID: 25041849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
    Lee K; Jeong SH; Yoo SH; Ku JH
    Investig Clin Urol; 2022 Jan; 63(1):14-20. PubMed ID: 34983118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy.
    Kim SB; Yoon SG; Tae J; Kim JY; Shim JS; Kang SG; Cheon J; Lee JG; Kim JJ; Kang SH
    Investig Clin Urol; 2018 Mar; 59(2):98-105. PubMed ID: 29520385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Narrow Band Imaging in the Detection and Resection of Bladder Tumor in Transitional Cell Carcinoma of the Bladder: A Prospective, Blinded, Sequential Intervention Randomized Controlled Trial.
    Mukherjee P; George AJP; Yadav BK; Jeyaseelan L; Kumar RM; Mukha RP; Chandrasingh J; Kumar S; Kekre NS; Devasia A
    Urology; 2019 Jun; 128():55-61. PubMed ID: 30822478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is a routine second transurethral resection of the bladder still necessary after hexaminolévulinate photodynamic diagnosis-assisted TURBT?].
    Doisy L; Walz J; Fakhfakh S; Rybikowski S; Koskas Y; Gravis G; Pignot G
    Prog Urol; 2019; 29(6):332-339. PubMed ID: 31104952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
    Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
    Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results.
    Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J;
    Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
    Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
    BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.
    Lodde M; Mayr R; Martini T; Comploj E; Palermo S; Trenti E; Hanspeter E; Fritsche HM; Mian C; Pycha A
    World J Urol; 2012 Dec; 30(6):841-6. PubMed ID: 23143733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer.
    Giunchi F; Panzacchi R; Capizzi E; Schiavina R; Brunocilla E; Martorana G; D'Errico A; Fiorentino M
    Clin Genitourin Cancer; 2016 Aug; 14(4):e307-12. PubMed ID: 26874973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NBI - plasma vaporization hybrid approach in bladder cancer endoscopic management.
    Stănescu F; Geavlete B; Georgescu D; Jecu M; Moldoveanu C; Adou L; Bulai C; Ene C; Geavlete P
    J Med Life; 2014 Jun; 7(2):155-9. PubMed ID: 25408719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second Transurethral Resection (TUR) for Bladder Cancer Diagnosed with High Grade pT1 by Initial TUR Under Narrow Band Imaging].
    Mita K; Kobatake K; Ohara S; Kato M; Nomura N; Murata D; Mochizuki H
    Hinyokika Kiyo; 2019 Dec; 65(12):501-506. PubMed ID: 31933334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
    Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
    Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-look TURBT: evaluation of anatomopatological and oncologic results in a single center.
    Maltagliati M; Varca V; Milandri R; Micali S; Bocchialini T; Rocco BMC; Gregori A
    Acta Biomed; 2020 May; 91(2):322-325. PubMed ID: 32420968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for re-TUR of the bladder in non-muscle invasive bladder cancer: risk factors of tumor persistence in re-TUR specimens.
    Husillos Alonso A; Rodríguez Fernández E; Herranz Amo F; López López E; Aragón Chamizo J; Ramírez Martínez D; Durán Merino R; Hernández Fernández C
    Minerva Urol Nefrol; 2014 Dec; 66(4):233-40. PubMed ID: 25531192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.